Literature DB >> 11552085

The neurologic complications of scleromyxedema.

J R Berger1, M R Dobbs, M H Terhune, W F Maragos.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11552085     DOI： 10.1097/00005792-200109000-00005

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN： 0025-7974            Impact factor:   1.889


× No keyword cloud information.
  6 in total

1.  Monoclonal gammopathy of undetermined significance: significant beyond hematology.

Authors:  Steven Vanderschueren; Marieke Mylle; Daan Dierickx; Michel Delforge; Peter Verhamme; Kathelijne Peerlinck; Wouter Meersseman; Daniël C Knockaert
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

2.  [Arndt-Gottron syndrome with encephalopathy: complete recovery after immunosuppressive therapy].

Authors:  H Schmidt; P Schramm; Th Fuchs; M Bähr; P Lingor
Journal:  Nervenarzt       Date:  2011-10       Impact factor: 1.214

3.  Dermato-neuro syndrome in a case of scleromyxedema.

Authors:  Yusuf Savran; Sevgi Akarsu
Journal:  Eur J Rheumatol       Date:  2015-04-22

Review 4.  New insights on scleromyxedema.

Authors:  Laura Atzori; Caterina Ferreli; Franco Rongioletti
Journal:  J Scleroderma Relat Disord       Date:  2019-01-29

Review 5.  Scleroderma-like fibrosing disorders.

Authors:  Francesco Boin; Laura K Hummers
Journal:  Rheum Dis Clin North Am       Date:  2008-02       Impact factor: 2.670

6.  [Differential diagnose of angioedema. Acute edematous scleromyxedema].

Authors:  S Gerstner; H Kneitz; E-B Bröcker; A Trautmann
Journal:  Hautarzt       Date:  2014-05       Impact factor: 0.751
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.